MedTrace Logo

The Nordic Rectal Prolapse Study

NCT05569980 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 430

Last updated 2025-01-23

No results posted yet for this study

Summary

The goal of this observational study is to gather data about surgical procedures for rectal prolapse in adult human subjects. The main question it aims to answer is:

• Which procedure is best for treating external rectal prolapse?

Participants will:

* be included if they can consent to participation
* be offered standard care treatment, as no interventions will be done
* be asked to answer relevant questionnaires within 3 months prior to the surgery for rectal prolapse
* be asked to answer the same questionnaires 6 and 12 months postoperative
* optionally answer the questionnaires again at 3 and 1 year postoperative, but this is not part of the existing funding body

Conditions

  • Rectal Prolapse
  • Surgery
  • Recurrence
  • Quality of Life

Sponsors & Collaborators

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • Esbjerg Hospital - University Hospital of Southern Denmark

    collaborator OTHER

  • Universitätsmedizin Mannheim

    collaborator OTHER

  • Odense University Hospital

    collaborator OTHER

  • Hillerod Hospital, Denmark

    collaborator OTHER

  • Groene Hart Ziekenhuis

    collaborator OTHER

  • ASZ Aalst

    collaborator OTHER

  • Aarhus University Hospital

    lead OTHER

Principal Investigators

  • Peter Christensen, Prof., MDSc · Aarhus University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2026-12-31
Completion
2027-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05569980 on ClinicalTrials.gov